Relative Bioavailability and Activity of Different Formulations of Insulin Glargine and Lixisenatide in Patients With Diabetes Mellitus Type 1
Clinical trial NCT01146678 · COMPLETED
Trial details
- NCT number
- NCT01146678
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2010-09-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.